Europe is experiencing a report variety of outbreaks of mosquito-borne sicknesses in 2025, together with chikungunya.
New information printed in the present day by the Italian Istituto Superiore di Sanità (ISS) signifies that the nation’s struggle in opposition to chikungunya fever continued all through the early weeks of August 2025.
On August 21, 2025, ISS reported 4 native transmission occasions of the chikungunya virus had been recognized within the northern areas of Emilia-Romagna and Veneto in two outbreaks.
Chikungunya is a viral illness transmitted to individuals by virus-carrying mosquitoes, typically present in these areas’ altitudes, by means of November annually.
From January to August 19, 2025, Italy’s nationwide surveillance system has recorded 66 confirmed instances of chikungunya (37 travel-associated instances and 29 indigenous (native) instances, and no associated deaths, with a median age of 53 years.
From a prevention perspective, the U.S. CDC recommends both of the 2 accredited chikungunya vaccines for worldwide vacationers visiting outbreak zones in 2025.
These vaccines, and different travel vaccines, are commercially provided at licensed clinics and pharmacies in the US.